Learn More
Siemens Healthineers PFA-100 Instrument (US/CA)
The PFA-100™ System measures the complex process of primary hemostasis and aids in the rapid detection of platelet dysfunction. It is the first commercially available in vitro testing system to incorporate high-shear flow in which the process of platelet adhesion and aggregation following a vascular injury is simulated in-vitro.
Supplier: Siemens Healthineers 10459298
Description
The PFA-100™ System provides automated assessment for inherited, acquired, or drug-induced platelet dysfunction.
- Helps detect inherited, acquired and drug-induced platelet dysfunction
- Screening test for patients with impaired primary hemostasis, such as von Willebrand disease
- Verifies efficacy of desmopressin acetate (DDAVP) therapy in pre-surgical patients
- Assesses the platelet dysfunction due to the effect of Aspirin
- Evaluates platelet dysfunction in children over 1 year of age
- Evaluates platelet dysfunction in multiple clinical settings, such as presurgical screening, high-risk pregnancy and menorrhagia
Specifications
Hemostasis System | |
Citrated Whole Blood | |
Single Test: Col/EPI or Col/ADP: 6 tests/hour; Duplicate Test: Col/EPI or Col/ADP: 10 tests/hour | |
High-shear force dynamic flow system |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.